- Home
- EVAX vs SDOT Comparison
EVAX vs SDOT Comparison
Compare EVAX & SDOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVAX
- SDOT
- Stock Information
- Founded
- EVAX 2008
- SDOT 2014
- Country
- EVAX Denmark
- SDOT United States
- Employees
- EVAX N/A
- SDOT N/A
- Industry
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- SDOT Restaurants
- Sector
- EVAX Health Care
- SDOT Consumer Discretionary
- Exchange
- EVAX Nasdaq
- SDOT Nasdaq
- Market Cap
- EVAX 16.3M
- SDOT 14.2M
- IPO Year
- EVAX 2021
- SDOT 2020
- Fundamental
- Price
- EVAX $2.53
- SDOT $3.38
- Analyst Decision
- EVAX Strong Buy
- SDOT Hold
- Analyst Count
- EVAX 3
- SDOT 1
- Target Price
- EVAX $33.33
- SDOT N/A
- AVG Volume (30 Days)
- EVAX 6.8M
- SDOT 28.3K
- Earning Date
- EVAX 03-26-2025
- SDOT 03-19-2025
- Dividend Yield
- EVAX N/A
- SDOT N/A
- EPS Growth
- EVAX N/A
- SDOT N/A
- EPS
- EVAX N/A
- SDOT 0.35
- Revenue
- EVAX $3,295,000.00
- SDOT $655,938,000.00
- Revenue This Year
- EVAX $9,039.73
- SDOT $1.20
- Revenue Next Year
- EVAX $1.47
- SDOT $29.55
- P/E Ratio
- EVAX N/A
- SDOT $9.70
- Revenue Growth
- EVAX N/A
- SDOT N/A
- 52 Week Low
- EVAX $2.22
- SDOT $2.24
- 52 Week High
- EVAX $22.05
- SDOT $7.00
- Technical
- Relative Strength Index (RSI)
- EVAX 40.91
- SDOT 60.49
- Support Level
- EVAX $2.43
- SDOT $3.01
- Resistance Level
- EVAX $2.80
- SDOT $2.95
- Average True Range (ATR)
- EVAX 0.31
- SDOT 0.19
- MACD
- EVAX 0.07
- SDOT 0.10
- Stochastic Oscillator
- EVAX 16.94
- SDOT 98.85
About EVAX Evaxion Biotech
Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.
About SDOT Sadot Group Inc.
Sadot Group Inc operates in the food supply chain sector, connecting producers and consumers across the globe, delivering agri-commodities from producing geographies such as the Americas, Africa, and the Black Sea to consumer markets in Southeast Asia, China, and the Middle East/North Africa (MENA) region. Its reportable segment includes Sadot food service and Sadot agri-foods. The key revenue is coming from the Sadot agri-foods segment which engaged in farming, commodity trading, and shipping of food and feed.